Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.
Completed · Not applicable
Conditions studied: Coronary Artery Disease
In brief
The objective of this study is to verify the safety and efficacy of the Endeavor Zotarolimus-Eluting Coronary Stent System for improving coronary luminal diameter in patients with ischemic heart disease due to de novo lesions of length ≤27 mm in native coronary arteries with reference vessels ≥ 2.25 mm to ≤ 2.75 mm.
Key facts
- Study ID
- NCT00609947
- Run by
- Medtronic Vascular
- People needed
- 241
- Starts
- 2008-01-01
- Expected to finish
- 2013-09-01
- Last updated by the study team
- 2015-02-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- AnMed Health Medical Center — Anderson, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.